A similar anti-inflammatory effect of MSC was noted in vivo, in the model of tumor xenotransplantation described above, where quantitative RNA analysis of tumors removed at five days after injection revealed a tendency of decrease in the CD45 mRNA level in U87+ MSC group, as compared to U87 group (Figure 6D). This evidence concerns the gene PTPRC and neoplasm.